Jessica D Lang, Ph.D.
Affiliations: | 2021- | Pathology and Laboratory Medicine | University of Wisconsin, Madison, Madison, WI |
Google:
"Jessica Lang"Parents
Sign in to add mentor| Yoshihiro Kawaoka | research assistant | 2006-2008 | (Microtree) |
| David F. Jarrard | research assistant | 2008-2009 | (Cell Biology Tree) |
| Elaine T. Alarid | grad student | 2009-2014 | (Chemistry Tree) |
| Raymond N. DuBois | post-doc | 2014-2016 | Arizona State (Cell Biology Tree) |
| Jeffrey M. Trent | post-doc | 2016-2021 | The Translational Genomics Research Institute (TGen) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wei J, Zhang J, Wang D, et al. (2022) The COX-2-PGE2 pathway promotes tumor evasion in colorectal adenomas. Cancer Prevention Research (Philadelphia, Pa.) |
| Halperin RF, Hegde A, Lang JD, et al. (2021) Improved methods for RNAseq-based alternative splicing analysis. Scientific Reports. 11: 10740 |
| Orlando KA, Douglas AK, Abudu A, et al. (2020) Re-expression of SMARCA4/BRG1 in Small Cell Carcinoma of Ovary, Hypercalcemic Type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism. Elife. 9 |
| Soldi R, Ghosh Halder T, Weston A, et al. (2020) The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer. Plos One. 15: e0235705 |
| Tischkowitz M, Huang S, Banerjee S, et al. (2020) Small Cell Carcinoma of the Ovary, Hypercalcaemic Type - genetics, new treatment targets and current management guidelines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Cen B, Lang JD, Du Y, et al. (2019) Prostaglandin E2 Induces MIR675-5p to Promote Colorectal Tumor Metastasis via Modulation of p53 Expression. Gastroenterology |
| Wang Y, Chen SY, Colborne S, et al. (2018) Histone deacetylase inhibitors synergizes with catalytic inhibitors of EZH2 to exhibit anti-tumor activity in small cell carcinoma of the ovary, hypercalcemic type. Molecular Cancer Therapeutics |
| Lang JD, Hendricks WPD, Orlando KA, et al. (2018) Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multi-kinase inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Lang JD, Hendricks WPD. (2018) Identification of Driver Mutations in Rare Cancers: The Role of SMARCA4 in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT). Methods in Molecular Biology (Clifton, N.J.). 1706: 367-379 |
| Wang Y, Chen SY, Karnezis AN, et al. (2017) The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcemic type. The Journal of Pathology |